Characterization Of Tl-895: A Novel Bruton Tyrosine Kinase Inhibitor (Btki) In Clinical Development For Chronic Lymphocytic Leukemia (Cll) And Myelofibrosis (Mf)
TL-895
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Characterization Of Tl-895: A Novel Bruton Tyrosine Kinase Inhibitor (Btki) In Clinical Development For Chronic Lymphocytic Leukemia (Cll) And Myelofibrosis (Mf) ### Output: TL-895